You are here

Cellerant Therapeutics, Inc.

Company Information
Address
1561 Industrial Rd
San Carlos, CA 94070-4111
United States


http://www.cellerant.com

Information

UEI: LML1YE6L8KU3

# of Employees: 50


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Novel Indication for Myeloid Progenitor Use: Induction of Tolerance in Solid Organ Transplantation

    Amount: $1,117,159.00

    PROJECT SUMMARY State of the art techniques result inyear solid organ graft loss ofto overin cardiopulmonary organ transplantationEstablishment of donor specific immunological toleranceDSITa condition ...

    STTRPhase II2018Department of Health and Human Services National Institutes of Health
  2. IGF OT IGF SBIR PHASE II TOPIC DEVELOPMENT OF NOVEL THERAPEUTIC AGENTS THAT TARGET CANCER STEM CELLS

    Amount: $1,496,276.00

    The effectiveness of current AML treatments is abysmal yielding only an overall year survival rate of and it has been hypothesized that the treatment may be more durable if leukemic stem cells ...

    SBIRPhase II2016Department of Health and Human Services National Institutes of Health
  3. OTHER FUNCTION: Development of IL1RAP antibodies targeting AML CS

    Amount: $223,524.00

    Not Available

    SBIRPhase I2014Department of Health and Human Services National Institutes of Health
  4. Novel indication for myeloid progenitor use: Induction of tolerance

    Amount: $200,787.00

    DESCRIPTION (provided by applicant): State of the art techniques result in 10-year solid organ graft loss of up to 80% in cardiopulmonary organ transplantation, and re-transplantation is often not pos ...

    STTRPhase I2013Department of Health and Human Services National Institutes of Health
  5. IGF::OT::IGF OTHER FUNCTIONS- RandD BIOMEDICAL (BASIC RESEARCH)

    Amount: $194,467.00

    The overall goal is to develop human allogeneic Megakaryocyte Progenitors (MKP, designated CL T-009) as a cell therapeutic to treat radiation induced thrombocytopenia in cancer patients. Thrombocytope ...

    SBIRPhase I2012Department of Health and Human Services National Institutes of Health
  6. Attenuation of Radiation-Induced GI Injury by Cultured Myeloid Progenitors

    Amount: $300,000.00

    DESCRIPTION (provided by applicant): Our long term goal is to develop a universal cell-based therapy containing human myeloid progenitor cells to attenuate radiation-induced gastrointestinal or hemato ...

    STTRPhase I2007Department of Health and Human Services National Institutes of Health
  7. Application of Expanded Myeloid Progenitors for Infection (Phase II)

    Amount: $2,045,700.00

    DESCRIPTION (provided by applicant): Cellerant has successfully completed the Phase I feasibility research for the development of a neutrophil progenitor for the treatment of neutropenia e.g. during b ...

    SBIRPhase II2006Department of Health and Human Services National Institutes of Health
  8. Application of expanded progenitors against infections

    Amount: $296,883.00

    DESCRIPTION (provided by applicant): Our long term goal is to develop a cell-based therapy containing human myeloid progenitor cells to enhance resistance to pathogens and recovery from infections af ...

    SBIRPhase I2005Department of Health and Human Services National Institutes of Health
  9. Expansion of HSC for rescue in biodefense applications

    Amount: $804,638.00

    DESCRIPTION (provided by applicant): Myeloablation is the damage that occurs to the bone marrow as a result of radiological or chemical exposure whether therapeutically administered or accidental, tha ...

    SBIRPhase I2004Department of Health and Human Services National Institutes of Health
  10. Validation of novel parallel hematopoietic cell sorter

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Hematopoietic cell transplantation is a component of standard therapy for many malignant hematological diseases and is actively being investigated for use in treat ...

    SBIRPhase I2003Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government